C-reactive protein for the prediction of cardiovascular risk: ready for prime-time?
Hackam
Daniel G
DG
Institute for Clinical Evaluative Sciences and Division of Clinical Pharmacology and Toxicology, Sunnybrook and Women's College Health Sciences Centre, University of Toronto, Toronto, Ont. danhackman@rogers.com
Shumak
Steven L
SL
D000208:Acute Disease; D001364:Awareness; D002097:C-Reactive Protein / Q000378:metabolism*; D002318:Cardiovascular Diseases / Q000175:diagnosis / Q000378:metabolism* / Q000517:prevention & control*; D016022:Case-Control Studies; D015331:Cohort Studies; D003430:Cross-Sectional Studies; D006801:Humans; D011237:Predictive Value of Tests; D012307:Risk Factors
D002097:C-Reactive Protein